NCT00568230View on ClinicalTrials.gov

Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

November 30, 2008

Conditions
Heart FailureMitral Regurgitation
Interventions
DEVICE

PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant

Percutaneous access from right or left subclavian vein with placement of assessment and placement of PTMA Implant into the coronary sinus, great cardiac vein. Device remains accessible from a subclavicular pocket.

Trial Locations (1)

Unknown

Universitat Duisburg-Essen, Essen

All Listed Sponsors
lead

Viacor

INDUSTRY

NCT00568230 - Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation | Biotech Hunter | Biotech Hunter